Aion Therapeutic Inc (TSE:AION) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aion Therapeutic Inc. has updated stakeholders on the progress of its annual financial disclosures delayed due to complexities from acquiring Toppen Health, Inc. The company is under a management cease trade order but expects to meet the new October 28 deadline set by the British Columbia Securities Commission. No new material changes or defaults have been reported, and the company continues to comply with alternative information guidelines.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.